These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 23753907)
1. Error in Author's Name in: Intravitreal Bevacizumab for Peripapillary Choroidal Neovascular Membranes. Arch Ophthalmol; 2012 Nov; 130(11):1473. PubMed ID: 23753907 [No Abstract] [Full Text] [Related]
2. Treatment of peripapillary choroidal neovascular membranes with intravitreal bevacizumab. Figueroa MS; Noval S; Contreras I Br J Ophthalmol; 2008 Sep; 92(9):1244-7. PubMed ID: 18621798 [TBL] [Abstract][Full Text] [Related]
3. Intravitreal bevacizumab for peripapillary subretinal neovascular membrane associated to papilledema: a case report. Más AM; Villegas VM; García JM; Acevedo S; Serrano L P R Health Sci J; 2012 Sep; 31(3):148-50. PubMed ID: 23038888 [TBL] [Abstract][Full Text] [Related]
4. Intravitreal bevacizumab for peripapillary choroidal neovascular membranes. Davis AS; Folk JC; Russell SR; Sohn EH; Boldt HC; Stone EM; Mahajan VB Arch Ophthalmol; 2012 Aug; 130(8):1073-5. PubMed ID: 22893085 [No Abstract] [Full Text] [Related]
5. Peripapillary choroidal neovascular membrane in a teenage boy: presenting feature of idiopathic intracranial hypertension and resolution with intravitreal bevacizumab. Belliveau MJ; Xing L; Almeida DR; Gale JS; ten Hove MW J Neuroophthalmol; 2013 Mar; 33(1):48-50. PubMed ID: 23403388 [TBL] [Abstract][Full Text] [Related]
6. Treatment of neovascular age-related macular degeneration with intravitreal bevacizumab: efficacy of three consecutive monthly injections. Melamud A; Stinnett S; Fekrat S Am J Ophthalmol; 2008 Jul; 146(1):91-5. PubMed ID: 18455144 [TBL] [Abstract][Full Text] [Related]
7. Intravitreal bevacizumab (avastin) for choroidal neovascularization associated with deferoxamine retinopathy. Duval R; Olivier S Retin Cases Brief Rep; 2011; 5(3):233-6. PubMed ID: 25390172 [TBL] [Abstract][Full Text] [Related]
8. Intravitreal bevacizumab in the treatment of peripapillary choroidal neovascular membrane secondary to idiopathic intracranial hypertension. Lee IJ; Maccheron LJ; Kwan AS J Neuroophthalmol; 2013 Jun; 33(2):155-7. PubMed ID: 23235432 [TBL] [Abstract][Full Text] [Related]
9. Intravitreal bevacizumab for treatment of peripapillary subretinal neovascularization. Caccavale A; Imparato M; Negri A Retin Cases Brief Rep; 2008; 2(2):145-7. PubMed ID: 25389827 [TBL] [Abstract][Full Text] [Related]
10. Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Rich RM; Rosenfeld PJ; Puliafito CA; Dubovy SR; Davis JL; Flynn HW; Gonzalez S; Feuer WJ; Lin RC; Lalwani GA; Nguyen JK; Kumar G Retina; 2006; 26(5):495-511. PubMed ID: 16770255 [TBL] [Abstract][Full Text] [Related]
11. Intravitreal bevacizumab in the management of posttraumatic choroidal neovascular membrane. Rishi P; Shroff D; Rishi E Retin Cases Brief Rep; 2008; 2(3):236-8. PubMed ID: 25390097 [TBL] [Abstract][Full Text] [Related]
12. [Intravitreal injections of ranibizumab in treatment of large peripapillary choroidal neovascularization]. Nochez Y; Le Lez ML; Pisella PJ J Fr Ophtalmol; 2009 Jan; 32(1):25-31. PubMed ID: 19515310 [TBL] [Abstract][Full Text] [Related]
13. Bevacizumab for neovascular ocular diseases. Lynch SS; Cheng CM Ann Pharmacother; 2007 Apr; 41(4):614-25. PubMed ID: 17355998 [TBL] [Abstract][Full Text] [Related]
14. Successful treatment of choroidal neovascularization complicating a choroidal osteoma with intravitreal bevacizumab. Rao S; Gentile RC Retin Cases Brief Rep; 2010; 4(4):303-5. PubMed ID: 25390904 [TBL] [Abstract][Full Text] [Related]